News

When a visionary study of Australian women’s health was launched in the 1990s, high-quality data was scarce and crippling conditions such as endometriosis under-recognised.

A new PhD scholarship to honour the legacy of the late Robert (Bob) Edwards is backing research at the University of Newcastle to develop urgent treatments for childhood brain cancer.

A $1.7 million donation from The Phare Trust will fund a new PhD scholarship supporting impactful research in health service delivery, health policy, workforce planning, and population health challenges in regional and disadvantaged communities.

The Ma & Morley Scholarship Program’s aim is to inspire, educate and cultivate the next generation of globally aware and socially conscious Australian leaders. Recent graduate, Dr Tanika Ridgeway, is already changing the way we approach Aboriginal and Torres Strait Islander health in Australia.

The University of Newcastle and CareerTrackers today officially launched a partnership to support Aboriginal and Torres Strait Islander students into meaningful careers, internships and leadership opportunities.

New research suggests most Australians support a simple change that could significantly boost children’s physical activity levels: letting students wear sports uniforms every day.

New research from the University of Newcastle has found that people with irritable bowel syndrome (IBS) show detectable biological changes, challenging the long-held perception that the condition lacks a physical basis.

No money, no time to cook healthy?  Two leading health organisations have joined forces to help show people in Australia how simple it can be to cook heart-healthy meals on a budget.

Hunter Medical Research Institute (HMRI) has unveiled a major upgrade to imaging capabilities with the installation of a new Siemens Healthineers MAGNETOM Cima.X Fit MRI scanner at the Hunter Medical Research Institute Imaging Centre, strengthening the region's capacity for world-class medical research.

Popular GLP-1 and GIP medications, such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro) and liraglutide (Saxenda) are changing the way obesity and type 2 diabetes are viewed and treated.

Technology created at The University of Queensland, in collaboration with Newcastle researchers, could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions.

The University of Newcastle is proud to congratulate all recipients who have been recognised in the 2026 Australia Day Honours, particularly those who make up the vibrant and growing University community.